Engineered lipid hybrid nanoparticles for targeted delivery of SH2 superbinder and breast cancer therapy
Abstract SH2 Superbinder (SH2S) is an engineered polypeptide tool derived from the SH2 domain. It exhibits significantly enhanced binding capacity for tyrosine-phosphorylated proteins to treat various cancers. However, its clinical application is limited by poor serum stability and insufficient tumo...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-03-01
|
| Edice: | Journal of Nanobiotechnology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12951-026-04249-w |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
